(UroToday.com) The 2021 American Society of Clinical Oncology (ASCO) program included a session discussing the application of genomic testing treatments for patients with prostate cancer, including a presentation by Dr. Franklin Huang discussing the medical oncology perspective of the promise and limitations of precision health in metastatic disease.